CTOs on the Move

Lyra Therapeutics

www.lyratherapeutics.com

 
Creating precisely tuned medicines so patients can breathe freely, we are pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that impact the lives of millions of people. Lyra Therapeutics is a clinical-stage company pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people. Our goal is to transform the ENT treatment paradigm by providing effective front-line solutions for physicians and new treatment options for their patients. Lyra`s transmucosal therapeutic system, now being evaluated in a clinical study, directly targets tissues that are difficult ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
John Bishop
 Chief Technology Officer Profile

Funding

Lyra Therapeutics raised $30M on 01/29/2020
Lyra Therapeutics raised $100.5M on 04/08/2022

Similar Companies

Natrol

Natrol, Inc. (Natrol) manufactures and markets dietary supplements, herbal teas, and sports nutrition products under three primary brands: Natrol, Laci Le Beau, and Prolab. Through its Essentially Pure Ingredients (EPI) division, the Company sells

Headcan

Headcan is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emendo Biotherapeutics

Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.

MAPS Public Benefit Corporation

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics.

NestleHealthScience

Nestle Health Science is pioneering a new field where nutrition becomes therapy. We are changing the course of health through research and innovation, and nutritional therapies. Visit the site to learn more.